We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
The current IOVA market cap is 3.27B. The company's latest EPS is USD -1.5898 and P/E is -7.36.
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 0 | 0 | 238k | 469k |
| Operating Income | -100.4M | -107.04M | -110.86M | -110.09M | -118.36M |
| Net Income | -99.62M | -105.32M | -107.37M | -106.53M | -113.76M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 0 | 0 | 0 | 1.19M |
| Operating Income | -206.87M | -261.94M | -342.7M | -398.88M | -460.56M |
| Net Income | -197.56M | -259.58M | -342.25M | -395.89M | -444.04M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 545.92M | 663.98M | 824.77M | 757.29M | 852.32M |
| Total Liabilities | 152.19M | 164.34M | 157.89M | 178.72M | 178.31M |
| Total Equity | 393.74M | 499.64M | 666.88M | 578.57M | 674.01M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 344.66M | 768.46M | 777.33M | 663.98M | 780.35M |
| Total Liabilities | 45.68M | 111.96M | 155.67M | 164.34M | 195.74M |
| Total Equity | 298.97M | 656.5M | 621.66M | 499.64M | 584.61M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -215.09M | -292.76M | -99.82M | -193.77M | -277.85M |
| Investing | 255.99M | 256.46M | 153.4M | -3.38M | -82.4M |
| Financing | -425k | 190.15M | 258.17M | 259.2M | 462M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -158.89M | -205.13M | -227.94M | -292.76M | -361.82M |
| Investing | 90.03M | -317.85M | 132k | 256.46M | -155.24M |
| Financing | 6.13M | 576.42M | 239.27M | 190.15M | 462.96M |
| Market Cap | 3.27B |
| Price to Earnings Ratio | -7.36 |
| Price to Sales Ratio | 2.72k |
| Price to Cash Ratio | 28.45 |
| Price to Book Ratio | 5.59 |
| Dividend Yield | - |
| Shares Outstanding | 279.31M |
| Average Volume (1 week) | 3.68M |
| Average Volume (1 Month) | 4.46M |
| 52 Week Change | 102.25% |
| 52 Week High | 18.33 |
| 52 Week Low | 3.21 |
| Spread (Intraday) | 0.32 (2.68%) |
| Company Name | Iovance Biotherapeutics Inc |
| Address |
2140 s dupont hwy camden, delaware 19934 |
| Website | https://www.iovance.com |
| Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
